Clinical Trials
7 trialsNCT05453006 2025-07-10
Isbaar
University of Minnesota
Phase NA Completed
NCT03487549 2024-11-27
COVE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT01567813 2022-07-22
Post-Licensure Study of the Safety of GARDASILâ„¢ in Males (V501-070)
Merck Sharp & Dohme LLC
Completed
NCT00000764 2021-10-28
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT01478685 2019-11-12
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Celgene
Phase 1 Completed
NCT00001560 2017-07-02
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
National Institutes of Health Clinical Center (CC)
Completed
NCT01598779 2015-12-21
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
University of Buenos Aires
Completed